Abstract:Abstract Background Contemporaneous data are required for women with chronic kidney disease (CKD) Stages 3–5 to inform pre-pregnancy counselling and institute appropriate antenatal surveillance. Methods A retrospective cohort study in women with CKD Stages 3–5 after 20 weeks’ gestation was undertaken in six UK tertiary renal centres in the UK between 2003 and 2017. Factors predicting adverse outcomes and the impact of pregnancy in accelerating the need for renal replacement therapy (RRT) were assessed. Results There were 178 pregnancies in 159 women, including 43 women with renal transplants. The live birth rate was 98%, but 56% of babies were born preterm (before 37 weeks’ gestation). Chronic hypertension was the strongest predictor of delivery before 34 weeks’ gestation. Of 121 women with known pre-pregnancy hypertension status, the incidence of delivery before 34 weeks was 32% (31/96) in women with confirmed chronic hypertension compared with 0% (0/25) in normotensive women. The risk of delivery before 34 weeks doubled in women with chronic hypertension from 20% [95% confidence interval (CI) 9–36%] to 40% (95% CI 26–56%) if the gestational fall in serum creatinine was <10% of pre-pregnancy concentrations. Women with a urinary protein:creatinine ratio >100 mg/mmol prior to pregnancy or before 20 weeks’ gestation had an increased risk for birthweight below the 10th centile (odds ratio 2.57, 95% CI 1.20–5.53). There was a measurable drop in estimated glomerular filtration rate (eGFR) between pre-pregnancy and post-partum values (4.5 mL/min/1.73 m2), which was greater than the annual decline in eGFR prior to pregnancy (1.8 mL/min/1.73 m2/year). The effect of pregnancy was, therefore, equivalent to 1.7, 2.1 and 4.9 years of pre-pregnancy renal disease in CKD Stages 3a, 3b and 4–5, respectively. The pregnancy-associated decline in renal function was greater in women with chronic hypertension and in those with a gestational fall in serum creatinine of <10% of pre-pregnancy concentrations. At 1 year post-partum, 46% (58/126) of women had lost ≥25% of their pre-pregnancy eGFR or required RRT. Most women with renal transplants had CKD Stage 3 and more stable renal function prior to pregnancy. Renal transplantation was not independently associated with adverse obstetric or renal outcomes. Conclusions Contemporary pregnancies in women with CKD Stages 3–5 are complicated by preterm delivery, low birthweight and loss of maternal renal function. Chronic hypertension, pre- or early pregnancy proteinuria and a gestational fall in serum creatinine of <10% of pre-pregnancy values are more important predictors of adverse obstetric and renal outcome than CKD Stages 3–5. Pregnancy in women with CKD Stages 3–5 advances the need for dialysis or transplantation by 2.5 years.

Pregnancies in Women with Kidney Failure on Home Dialysis in the United States

Pregnancy in Patients Receiving Home Dialysis

Pregnancy in Patients on Maintenance Hemodialysis: Seven Cases Report and 169 Reported Cases Review

Pregnancy Among Women Receiving Chronic Dialysis in France (2006-2020)

Delayed Initiation of Hemodialysis in Pregnant Women with Chronic Kidney Disease: Logistical Problems Impact Clinical Outcomes. An Experience from an Emerging Country

Successful Pregnancy and Delivery in Uremic Patients with Maintenance Hemodialysis

Successful Pregnancy after Protective Hemodialysis for Chronic Kidney Disease: A Case Report

The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes

Reproductive health and pregnancy in women with chronic kidney disease

Pregnancy and Family Planning in Women with Kidney Disease

Pregnancy outcomes post‐kidney transplantation across 23 years

A successful pregnancy and parturition in a patient with anuria undergoing maintenance hemodialysis for 6 years: a case report of a 3-year-follow-up

Pregnancy in Patients with Stage 3-5 CKD: Maternal and Fetal Outcomes

Pre-Pregnancy eGFR and the Risk of Adverse Maternal and Fetal Outcomes: A Population-Based Study

Pregnancy In Chronic Kidney Disease: Need For Higher Awareness. A Pragmatic Review Focused On What Could Be Improved In The Different Ckd Stages And Phases

Pregnancy outcomes in women with kidney transplant: Metaanalysis and systematic review

The pregnancy outcomes in patients with stage 3–4 chronic kidney disease and the effects of pregnancy in the long-term kidney function

Significant kidney disease in pregnancy: Feasibility and outcomes of a national population‐based study using the Australasian Maternity Outcomes Surveillance System

A Systematic Review And Meta-Analysis Of Outcomes Of Pregnancy In Ckd And Ckd Outcomes In Pregnancy

Kidney disease and reproductive health

Adverse pregnancy outcomes in pregnant women with chronic kidney disease: A systematic review and meta‐analysis